ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $505,000 | -25.6% | 374,195 | +60.4% | 0.00% | -100.0% |
| Q3 2021 | $679,000 | -42.8% | 233,340 | -31.4% | 0.00% | 0.0% |
| Q2 2021 | $1,187,000 | +15.4% | 340,068 | +13.0% | 0.00% | 0.0% |
| Q1 2021 | $1,029,000 | -64.5% | 300,832 | +99.1% | 0.00% | -66.7% |
| Q4 2020 | $2,901,000 | +110.8% | 151,100 | +47.5% | 0.00% | +200.0% |
| Q3 2020 | $1,376,000 | -67.9% | 102,453 | +1.4% | 0.00% | -80.0% |
| Q2 2020 | $4,280,000 | +53.9% | 101,075 | +0.4% | 0.01% | +25.0% |
| Q1 2020 | $2,781,000 | -23.5% | 100,707 | -10.1% | 0.00% | 0.0% |
| Q4 2019 | $3,634,000 | +99.2% | 111,997 | +59.8% | 0.00% | +100.0% |
| Q3 2019 | $1,824,000 | +412.4% | 70,084 | +281.7% | 0.00% | – |
| Q3 2018 | $356,000 | -22.4% | 18,359 | -11.7% | 0.00% | -100.0% |
| Q2 2018 | $459,000 | -40.2% | 20,782 | -42.6% | 0.00% | 0.0% |
| Q1 2018 | $767,000 | – | 36,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |